Pharma R&D Outsourcing Global Market Report 2022: Paradigm Shift Towards Virtual Clinical Trials Reshaping Sector – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pharma R&D Outsourcing Market – Global Outlook & Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. In a world of exponentially growing information, increasingly sophisticated technology, and an unstable economic environment, pharmaceutical corporations are increasingly outsourcing research efforts to academia and private contract research organizations (CROs). The pharmaceutical R&D outsourcing market is … [Read more…]

Instem Unveils New Additions to Its Leading Computational Toxicology Software Suite

New Functionality Along With Enhanced Models to Deliver More Efficient and Comprehensive Predictions in Chemical Safety PHILADELPHIA–(BUSINESS WIRE)–Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that the latest edition of its powerful Leadscope Model Applier Computational Toxicology software solution has been released. This latest update includes … [Read more…]

Walgreens Announces Agreement in Principle for Multi-State Opioid Settlement Framework

DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens today announced it has agreed in principle to financial amounts and payment terms as part of settlement frameworks to substantially resolve opioid-related litigation. Under these frameworks, the company expects to settle all opioid claims against it by participating states, subdivisions and tribes, for up to approximately $4.95 billion in remediation payments to … [Read more…]

AbCellera’s First Program with Regeneron in Multi-Target Collaboration Advances in Preclinical Development

VANCOUVER, British Columbia–(BUSINESS WIRE)–$ABCL—AbCellera (Nasdaq: ABCL) announced today that Regeneron has elected to exercise its right to advance a therapeutic antibody candidate, discovered in partnership with AbCellera as part of a multi-target collaboration between the companies, into further preclinical development. The partnership, which commenced in March 2020 and allows for four discovery programs selected by … [Read more…]

Prescription Drug Safety Network Reached More Than 22,000 Students with Prescription Drug Safety Digital Education During 2021-22 School Year

STAMFORD, Conn.–(BUSINESS WIRE)–Purdue Pharma L.P. lauds the Prescription Drug Safety Network (“the Network”) for educating thousands of students about prescription drug safety during the 2021-2022 school year. The Network, of which Purdue Pharma L.P. is a founding member, released annual impact data for the digital education curriculum it provides to middle and high school students … [Read more…]

Culligan International and Waterlogic Group Holdings Complete Combination

The combined company provides clean, sustainable drinking water to more than 100 million consumers and saves more than 40 billion plastic bottles annually ROSEMONT, Ill. & MAIDENHEAD, England–(BUSINESS WIRE)–Culligan International (“Culligan”), the innovative brand in consumer-focused, sustainable water solutions and services, and Waterlogic Group Holdings (“Waterlogic”), a global designer, manufacturer, distributor and service provider of … [Read more…]

Advancing Health Equity, Improving Health Outcomes for All Could Save U.S. $3.8 Trillion

New Data Elevate Access to Primary Care and Improved Adherence as Immediate Opportunities for Savings WASHINGTON–(BUSINESS WIRE)–#FacesofAcceleratedApproval–The Partnership to Fight Chronic Disease (PFCD) today released new data and analysis on the economic impact of achieving health equity in chronic disease outcomes through 2031. The analysis found that a total of $3.8 trillion in costs could … [Read more…]

Global Gastrointestinal Therapeutics Strategic Business Report 2022: Market to Reach $84.4 Billion by 2027 – Crohn’s Disease is Expected to Account for $16.3 Billion – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Gastrointestinal Therapeutics: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global Gastrointestinal Therapeutics Market to Reach $84.4 Billion by 2027 The global market for Gastrointestinal Therapeutics estimated at US$61.2 Billion in the year 2020, is projected to reach a revised size of US$84.4 Billion by 2027, growing at a CAGR … [Read more…]

Omnicell Announces Financial Results for Third Quarter 2022

GAAP and non-GAAP revenues of $348 million GAAP net income per diluted share of $0.37 Non-GAAP net income per diluted share of $1.00 SANTA CLARA, Calif.–(BUSINESS WIRE)–Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results … [Read more…]

LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022

ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s third quarter 2022 financial results will be released before market open on Wednesday, November 9, 2022. LENSAR’s management will host a conference call … [Read more…]